Lifecore Biomedical, Inc. Common Stock (LFCR) Stock Price

LFCRStock

$6.38−2.30%52W

Market Cap$241.84M

P/E—

PEG Ratio2.66

Div yield—

Beta1.00

LFCR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)12.79%

Price vs S&P 500 (4W)43.74%

PEG Ratio2.66

VGM Score50.37

P/CF (Annual)32.99x

Book Value / Share (Quarterly)$0.43

P/TBV (Annual)5.76x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-9.91%

Cash Flow / Share (Quarterly)$0.12

Price vs S&P 500 (YTD)-33.93%

Gross Margin (TTM)29.28%

Net Profit Margin (TTM)-29.93%

EPS (TTM)$-1.31

10-Day Avg Trading Volume0.75M

EPS Excl Extra (TTM)$-1.31

Revenue Growth (5Y)-15.13%

EPS (Annual)$-0.48

ROI (Annual)-10.19%

Gross Margin (Annual)31.37%

Net Profit Margin (5Y Avg)-40.52%

Cash / Share (Quarterly)$0.46

Revenue Growth QoQ (YoY)-6.25%

ROA (Last FY)-7.74%

Revenue Growth TTM (YoY)27.26%

EBITD / Share (TTM)$0.12

ROE (5Y Avg)-104.45%

Operating Margin (TTM)-3.60%

Cash Flow / Share (Annual)$0.10

P/B Ratio15.03x

P/B Ratio (Quarterly)12.24x

Net Income / Employee (Annual)$-47,000

EV / Revenue (TTM)2.32x

Net Interest Coverage (TTM)-0.13x

ROA (TTM)-21.29%

EV / EBITDA (TTM)85.11x

EPS Incl Extra (Annual)$-0.48

Current Ratio (Annual)3.49x

Quick Ratio (Quarterly)2.55x

3-Month Avg Trading Volume0.30M

52-Week Price Return-2.30%

EV / Free Cash Flow (Annual)104.48x

Revenue / Employee (TTM)$429,300

Tangible BV / Share (Quarterly)$0.87

P/S Ratio (Annual)3.20x

Asset Turnover (Annual)0.33x

52-Week High$8.98

Operating Margin (5Y Avg)-19.38%

EPS Excl Extra (Annual)$-0.48

CapEx CAGR (5Y)-31.08%

Tangible BV CAGR (5Y)-35.73%

26-Week Price Return22.69%

Quick Ratio (Annual)2.18x

13-Week Price Return36.32%

Total Debt / Equity (Annual)4.18x

Current Ratio (Quarterly)3.87x

Enterprise Value$379.67M

Revenue / Share Growth (5Y)-19.16%

Asset Turnover (TTM)0.71x

Book Value / Share Growth (5Y)-32.61%

Revenue / Employee (Annual)$197,700

Inventory Turnover (Annual)2.45x

Pretax Margin (Annual)-23.34%

Cash / Share (Annual)$0.47

3-Month Return Std Dev118.16%

Gross Margin (5Y Avg)29.90%

Net Income / Employee (TTM)$-128,500

EBITDA CAGR (5Y)-23.76%

EBITDA Interim CAGR (5Y)-6.63%

ROE (Last FY)-52.73%

Net Interest Coverage (Annual)-0.32x

EPS Basic Excl Extra (Annual)$-0.48

P/FCF (TTM)23.11x

Receivables Turnover (TTM)4.45x

EV / Free Cash Flow (TTM)84.11x

Total Debt / Equity (Quarterly)9.64x

EPS Incl Extra (TTM)$-1.31

Receivables Turnover (Annual)3.86x

ROI (TTM)-28.47%

P/S Ratio (TTM)1.47x

Pretax Margin (5Y Avg)-29.05%

Revenue / Share (Annual)$2.02

Tangible BV / Share (Annual)$1.17

Price vs S&P 500 (52W)-17.83%

Year-to-Date Return-22.00%

5-Day Price Return-0.93%

EPS Normalized (Annual)$-0.48

ROA (5Y Avg)-19.95%

Net Profit Margin (Annual)-23.78%

Month-to-Date Return-3.04%

Cash Flow / Share (TTM)$-1.85

EBITD / Share (Annual)$0.13

Operating Margin (Annual)-0.97%

LT Debt / Equity (Annual)3.98x

P/CF (TTM)24.57x

ROI (5Y Avg)-29.14%

LT Debt / Equity (Quarterly)9.23x

EPS Basic Excl Extra (TTM)$-1.31

P/TBV (Quarterly)8.46x

P/B Ratio (Annual)9.00x

Inventory Turnover (TTM)4.02x

Pretax Margin (TTM)-29.48%

Book Value / Share (Annual)$0.91

Price vs S&P 500 (13W)33.64%

Beta1.00x

P/FCF (Annual)66.55x

Revenue / Share (TTM)$4.36

ROE (TTM)-182.29%

52-Week Low$3.63

vGradeC

gGradeD

mGradeB

vgmGradeC

LFCR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.22	-$0.19	+14.61%(+$0.03)
Q1 2026	May 6, 2026	-$0.29	-$0.43	-48.28%(-$0.14)
Q4 2025	Mar 16, 2026	-$0.16	-$0.16	+0.00%(+$0.00)
Q1 2025	Apr 3, 2025	-$0.15	-$0.47	-213.33%(-$0.32)
Q4 2024	Jan 2, 2025	-$0.29	-$0.25	+13.79%(+$0.04)

LFCR Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.09

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
LFCRLifecore Biomedical, Inc. Common Stock	C	D	B	1.5x	27.3%	29.3%	—	$6.38
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Lifecore Biomedical, Inc. Common Stock

Lifecore Biomedical is a fully integrated CDMO providing development, manufacturing, and fill-finish services for complex sterile injectable pharmaceuticals. The company serves multiple delivery formats—syringes, vials, and cartridges—and operates two business segments: contract development and manufacturing services, and hyaluronic acid manufacturing.